Suzanne L Topalian - JoVE Visualize

Showing results (11-20 of 105) with videos related to

Pageof 11

Sort By:

Cancer Research|October 3, 2002

Revelation of a cryptic major histocompatibility complex class II-restricted tumor epitope in a novel RNA-processing enzymeSuzanne L Topalian, Monica I Gonzales, Yvona Ward, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 30, 2012

Structural insights into the editing of germ-line-encoded interactions between T-cell receptor and MHC class II by Vα CDR3Lu Deng, Ries J Langley, Qian Wang, et al.

Cancer Research|March 5, 2004

CD4(+) T-cell recognition of mutated B-RAF in melanoma patients harboring the V599E mutationMelinda S Sharkey, Gregory Lizée, Monica I Gonzales, et al.

Human Gene Therapy|April 30, 2003

Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expressionGregory Lizée, Joeri L Aerts, Monica I Gonzales, et al.

Journal of Translational Medicine|May 30, 2012

Workshop on immunotherapy combinations. Society for Immunotherapy of Cancer annual meeting Bethesda, November 3, 2011Ivan Martinez Forero, Hideho Okada, Suzanne L Topalian, et al.

Cancer Cell|August 18, 2023

Neoadjuvant immune checkpoint blockade: A window of opportunity to advance cancer immunotherapySuzanne L Topalian, Patrick M Forde, Leisha A Emens, et al.

Seminars in Oncology|August 31, 2015

Antagonists of PD-1 and PD-L1 in Cancer TreatmentEvan J Lipson, Patrick M Forde, Hans-Joerg Hammers, et al.

International Journal of Cancer|February 22, 2002

Tumor-specific CD8+ T lymphocytes derived from the peripheral blood of prostate cancer patients by in vitro stimulation with autologous tumor cell linesFranck Housseau, Daniel A Langer, Samuel D Oberholtzer, et al.

Journal for Immunotherapy of Cancer|December 18, 2014

Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockadeEvan J Lipson, Victor E Velculescu, Theresa S Pritchard, et al.

Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 10, 2004

Immunization of HLA-A*0201 and/or HLA-DPbeta1*04 patients with metastatic melanoma using epitopes from the NY-ESO-1 antigenHung T Khong, James C Yang, Suzanne L Topalian, et al.

Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:

Pageof 11

Cancer Research|October 3, 2002

Revelation of a cryptic major histocompatibility complex class II-restricted tumor epitope in a novel RNA-processing enzymeSuzanne L Topalian, Monica I Gonzales, Yvona Ward, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 30, 2012

Structural insights into the editing of germ-line-encoded interactions between T-cell receptor and MHC class II by Vα CDR3Lu Deng, Ries J Langley, Qian Wang, et al.

Cancer Research|March 5, 2004

CD4(+) T-cell recognition of mutated B-RAF in melanoma patients harboring the V599E mutationMelinda S Sharkey, Gregory Lizée, Monica I Gonzales, et al.

Human Gene Therapy|April 30, 2003

Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expressionGregory Lizée, Joeri L Aerts, Monica I Gonzales, et al.

Journal of Translational Medicine|May 30, 2012

Workshop on immunotherapy combinations. Society for Immunotherapy of Cancer annual meeting Bethesda, November 3, 2011Ivan Martinez Forero, Hideho Okada, Suzanne L Topalian, et al.

Cancer Cell|August 18, 2023

Neoadjuvant immune checkpoint blockade: A window of opportunity to advance cancer immunotherapySuzanne L Topalian, Patrick M Forde, Leisha A Emens, et al.

Seminars in Oncology|August 31, 2015

Antagonists of PD-1 and PD-L1 in Cancer TreatmentEvan J Lipson, Patrick M Forde, Hans-Joerg Hammers, et al.

International Journal of Cancer|February 22, 2002

Tumor-specific CD8+ T lymphocytes derived from the peripheral blood of prostate cancer patients by in vitro stimulation with autologous tumor cell linesFranck Housseau, Daniel A Langer, Samuel D Oberholtzer, et al.

Journal for Immunotherapy of Cancer|December 18, 2014

Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockadeEvan J Lipson, Victor E Velculescu, Theresa S Pritchard, et al.

Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 10, 2004

Immunization of HLA-A*0201 and/or HLA-DPbeta1*04 patients with metastatic melanoma using epitopes from the NY-ESO-1 antigenHung T Khong, James C Yang, Suzanne L Topalian, et al.

Pageof 11